Abstract 6736: Preclinical development of ADCT-241, a novel exatecan-based antibody-drug conjugate targeting PSMA for the treatment of prostate cancer

Authors: Ben Leatherdale, Beccie Martin, Banusha Rajeenthira, Cecile Oblette, Lara Montolio, Abigail Kimpalu, Pedro L. Alves, Hafsah Omar, Alison Faid, Elizabeth Horsley, Lina Baxter, Valenti Gomez, Charlie Britten, Lolke de Haan, Paul W. Hogg, Chris Pickford, Patrick H. van Berkel

Published: 2025-04-21

DOI: 10.1158/1538-7445.am2025-6736

Source: Full article